Education
About Us
Working with TipRanks
Follow Us
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H (HK:8329)
:8329
8329 Stock Chart & Stats
HK$0.15
>-HK$0.01(-0.63%)
At close: 4:00 PM EST
HK$0.15
>-HK$0.01(-0.63%)
Day’s Range― - ―
52-Week RangeHK$0.13 - HK$0.38
Previous CloseN/A
Volume90.00K
Average Volume (3M)399.33K
Market Cap
HK$239.95M
Enterprise ValueHK$334.74M
Total Cash (Recent Filing)HK$139.33M
Total Debt (Recent Filing)HK$101.89M
Price to Earnings (P/E)36.7
Beta0.11
Next Earnings
Apr 01, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 15, 2025Dividend Yield3.76%
Share Statistics
EPS (TTM)0.01
Shares Outstanding426,000,000
10 Day Avg. Volume274,000
30 Day Avg. Volume399,333
Financial Highlights & Ratios
PEG Ratio2.96
Price to Book (P/B)0.28
Price to Sales (P/S)0.25
P/FCF Ratio116.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
8329 FAQ
What was Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price range in the past 12 months?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H lowest stock price was HK$0.13 and its highest was HK$0.38 in the past 12 months.
What is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s market cap?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s market cap is HK$239.95M.
When is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s upcoming earnings report date?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s upcoming earnings report date is Apr 01, 2026 which is in 140 days.
How were Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s earnings last quarter?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H released its earnings results on Aug 22, 2025. The company reported HK$0.012 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.012.
Is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H overvalued?
According to Wall Street analysts Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price is currently Overvalued.
Does Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H pay dividends?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H pays a Notavailable dividend of HK$0.164 which represents an annual dividend yield of 3.76%. See more information on Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H dividends here
What is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s EPS estimate?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H have?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H has 426,000,000 shares outstanding.
What happened to Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price movement after its last earnings report?
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H reported an EPS of HK$0.012 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:8329
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
98.64%
12-Months-Change
Fundamentals
Return on Equity
0.72%
Trailing 12-Months
Asset Growth
-20.46%
Trailing 12-Months
Company Description
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H (8329) is a biotechnology company based in Shenzhen, China, specializing in the research, development, and production of high-quality biological products. The company operates primarily in the fields of health and environmental protection, offering a range of products including biopharmaceuticals, diagnostic reagents, and bio-agricultural solutions. With a strong focus on innovation and technology, Neptunus aims to improve public health and enhance food safety through its diverse portfolio.
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H (8329) Earnings & Revenues
Technical Analysis
Tianda Pharmaceuticals Ltd.
―
Wai Yuen Tong Medicine Holdings Limited
―
China NT Pharma Group Co., Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Huakang Biomedical Holdings Company Limited
―